Find clinical trials for Diabetes in Boston, MA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Diabetes trials near Boston, MA, USA:
The study is a prospective, randomized, 52-week double-blind, placebo-controlled, multicenter trial in subjects with T1D followed by a 2-year safety...
Phase 2
Boston, Massachusetts, United States and 22 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Boston, Massachusetts, United States and 17 other locations
blood sugar levels in adults at high risk of developing type 2 diabetes (prediabetes).Research suggests that vitamin D may play a role in bl...
Phase 3
Boston, Massachusetts, United States
for youth 10 to \<18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of an Afrezza plu...
Phase 2
Boston, Massachusetts, United States and 1 other location
This is a single arm feasibility study to evaluate the Omnipod M System in adults with Type 2 Diabetes with the aim to enroll to 40 particip...
Boston, Massachusetts, United States and 7 other locations
OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...
Phase 2
Boston, Massachusetts, United States and 24 other locations
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Fall River, Massachusetts, United States and 89 other locations
enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in adults with type 1 diabetes...
Boston, Massachusetts, United States and 2 other locations
pragmatic trial with open-label extension evaluating BT-001, an investigational digital therapeutic intended to help patients with type 2 diabetes...
Boston, Massachusetts, United States
The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.
Phase 3
East Providence, Rhode Island, United States and 96 other locations
Clinical trials
Research sites
Resources
Legal